Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Therapeutic Strategies of Matricellular Proteins in Cutaneous Wound Healing: Countervailing Chronic Wounds and Excessive Scarring.

Sylakowski, Kyle James (2022) Therapeutic Strategies of Matricellular Proteins in Cutaneous Wound Healing: Countervailing Chronic Wounds and Excessive Scarring. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

Download (5MB) | Preview


Cutaneous wound healing is an intricate orchestration of three overlapping phases of repair that encompass numerous cell types, signaling cascades, and microenvironment modifications to reach a successful resolution with minimal scarring. Disruption of any of these steps will create an abnormal healing response resulting in either chronic ulceration or excessive scarring. It has become evident that the extracellular matrix (ECM) and its associated components are key orchestrators during this process. A subclass of non-structural ECM proteins called matricellular proteins has taken to the forefront as possible targets for therapeutic strategies using ECM components due to their ability to mediate cell-ECM interactions. Here, we utilize two matricellular proteins significantly upregulated during the early or late phases of cutaneous wound healing – Tenascin-C (TNC) and Decorin (DCN). TNC is considered a vital on-switch for early phases of wound healing as it coordinates migration and survival signals of numerous cell types in the early stages of the hostile wound environment. Building upon previous work that showed TNC’s ability to promote survival of mesenchymal stem cells (MSCs) both in vitro and in vivo, we show that TNC enhances the therapeutic efficacy of MSCs through an improved ability to promote angiogenesis. DCN is the opposite of TNC as it is considered an essential off-switch for the tissue replacement phase of wound healing and limiting the occurrence of excessive scarring pathologies. Here we show DCN’s ability to improve wound healing outcomes and limit hypertrophic scarring in vivo during the resolution phase of repair. Ultimately, our work further emphasizes the potential use of matricellular proteins as therapeutic strategies to enhance cutaneous wound healing outcomes.


Social Networking:
Share |


Item Type: University of Pittsburgh ETD
Status: Unpublished
CreatorsEmailPitt UsernameORCID
Sylakowski, Kyle JamesKys13@pitt.eduKys130000-0002-2227-4032
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Thesis AdvisorWells, Alan H.wellsa@upmc.eduahw6
Committee ChairSoto-Gutiérrez, Alejandroals208@pitt.eduals208
Committee MemberStolz, Donna Beerdonna.stolz@pitt.edudstolz
Committee MemberVan Houten, Bennettvanhoutenb@upmc.eduBEV15
Committee MemberChu, Charleen T.ctc4@pitt.eductc4
Committee MemberWeinbaum, Justin S.juw51@pitt.edujuw51
Date: 2 May 2022
Date Type: Publication
Defense Date: 2 February 2022
Approval Date: 2 May 2022
Submission Date: 19 April 2022
Access Restriction: No restriction; Release the ETD for access worldwide immediately.
Number of Pages: 150
Institution: University of Pittsburgh
Schools and Programs: School of Medicine > Cellular and Molecular Pathology
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: Mesenchymal Stem Cells, Dynamic Reciprocity, Cell Therapy, Autophagy, Ischemia
Date Deposited: 02 May 2022 20:37
Last Modified: 02 May 2022 20:37


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item